Your browser doesn't support javascript.
loading
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration.
Krasniqi, Eriseld; Goeman, Frauke; Pulito, Claudio; Palcau, Alina Catalina; Ciuffreda, Ludovica; Di Lisa, Francesca Sofia; Filomeno, Lorena; Barba, Maddalena; Pizzuti, Laura; Cappuzzo, Federico; Sanguineti, Giuseppe; Maugeri-Saccà, Marcello; Ciliberto, Gennaro; Fanciulli, Maurizio; Blandino, Giovanni; Vici, Patrizia.
  • Krasniqi E; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Goeman F; SAFU Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Pulito C; Translational Oncology Research Unit, Department of Research, Advanced Diagnostic and Technological Innovation, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Palcau AC; Translational Oncology Research Unit, Department of Research, Advanced Diagnostic and Technological Innovation, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Ciuffreda L; SAFU Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Di Lisa FS; Phase IV Clinical Studies Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Filomeno L; Phase IV Clinical Studies Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Barba M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Pizzuti L; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Cappuzzo F; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Sanguineti G; Department of Radiation Oncology, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Maugeri-Saccà M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Ciliberto G; Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Fanciulli M; Scientific Direction, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Blandino G; SAFU Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Vici P; Translational Oncology Research Unit, Department of Research, Advanced Diagnostic and Technological Innovation, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Int J Mol Sci ; 23(23)2022 Nov 22.
Article en En | MEDLINE | ID: mdl-36498861
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / MicroARNs / Inhibidores de Proteínas Quinasas Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / MicroARNs / Inhibidores de Proteínas Quinasas Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article